Safeguarding Global Health

Sentinel-Enabled Biosecurity Preparedness for a Safer Future

Avicena’s Biosecurity Preparedness solution enables nations and organisations to build resilient systems for rapid identification and containment of potential outbreaks.

A Continuing Need to Safeguard Our Lives & Economies

As the world becomes more interconnected, the risk of pandemics causing widespread devastation has never been higher. 

The COVID-19 crisis revealed the inadequacy of global biosecurity infrastructure and the urgent need for stronger, more agile systems. 

Recognising the importance of biosecurity preparedness, governments are now investing in advanced solutions to create robust defences against future threats.

Avicena Sentinel Enables Biosecurity Preparedness

Avicena Sentinel is the world’s fastest and most scalable molecular diagnostics platform, with the capacity to handle up to 100,000 tests daily. 

The fully automated solution is economically viable for both low and high-volume testing, allowing for rapid self-collection of saliva or nasal samples in under 20 seconds. 

Offering accuracy comparable to PCR, the Avicena Sentinel outperforms in speed and cost, while also maintaining the ability to screen for multiple pathogens.


The Future of Biosecurity

Sentinel is flexible and can rapidly adapt to test for current and emerging pathogen threats

Emerging Threats

Lumpy Skin Disease
Japanese Encephalitis Virus
Zika Virus
Bioengineered Pathogens


Blood Banks

Hepatitis B
Hepatitis C

Antibiotic Resistant Pathogens

Drug-Resistant Tuberculosis


Human & Zoonotic influenza
Emerging Pandemic Flu Threats

Flexible Biosecurity Platform

Sentinel ULTRA V3

Up to 100,000 daily throughput
Continuous Flow Processing
Fully automated
Multiple IVD Test Formats with a Single Sample
Ability to Adapt to Other Pathogens
Low Staff & Space Needs
Real-Time LIM System Reporting


TGA Authorised

Sentinel has achieved a Class 1 IVD listing on the Australian Register of Therapeutic Goods (ARTG) under the TGA.

CE-Marked Chemistry

CE-Mark for COVID test chemistry developed by Hayat Genetics, acquired by Avicena Systems.



Avicena holds several patent pending innovations that enable our groundbreaking performance.

Intended Use

The Avicena Sentinel instrument is intended for trained laboratory professionals to run isothermal amplification assays. Diagnostic use of the Sentinel requires IVD reagents and laboratory workflows which have been authorised by relevant regulatory agencies in each jurisdiction and by Avicena Systems as compatible with the instrument.